home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/fcab8979-b4a7-4b96-ac02-15af9114d526_Thefinanci.pdf
whitepaper
SHARESHARESHARE
THE FINANCIALISATION OF BIG PHARMA
The affordability of and access to medicines has become a controversial topic. One of the key arguments put forward in defence of high drug prices is the cost of developing new products. In this report, we examine the role of a financialised business model in justifying the cost of medicines and the profit margins of pharmaceutical companies. DOWNLOAD